Findings from a small examine of eight sufferers counsel that COVID-19 rebound is probably going not brought on by impaired immune responses. The examine aimed to outline the scientific course and the immunologic and virologic traits of COVID-19 rebound in sufferers who’ve taken nirmatrelvir/ritonavir (Paxlovid).